Compounds > morpholinoanthracycline mx2

Page last updated: 2024-09-02

morpholinoanthracycline mx2 and Astrocytoma, Grade IV

morpholinoanthracycline mx2 has been researched along with Astrocytoma, Grade IV in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (75.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kaoru, K; Katsuzo, K; Tohru, U; Yasunori, K; Yuki, K	1
Arita, N; Hayakawa, T; Kuratsu, J; Kurisu, K; Uozumi, T; Ushio, Y	1
Bartlett, J; Basser, RL; Byrne, M; Cher, L; Clarke, K; Dalley, D; Findlay, M; Fox, RM; Geldard, H; Green, MD; Hill, JS; Kaye, AH; Maher, D; Mitchell, P; Pell, M; Underhill, C	1
Arita, N; Kayama, T; Kubo, N; Kuratsu, JI; Mori, T; Sawamura, Y; Ushio, Y	1

Trials

3 trial(s) available for morpholinoanthracycline mx2 and Astrocytoma, Grade IV

Article	Year
A phase II study of KRN8602(MX2), a novel morpholino anthracycline derivative, in patients with recurrent malignant glioma. Journal of neuro-oncology, 1999, Volume: 42, Issue:2 Topics: Adult; Aged; Antibiotics, Antineoplastic; Brain Neoplasms; Carubicin; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local	1999
KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:8 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Astrocytoma; Brain Neoplasms; Carubicin; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Survival Analysis	1999
Phase II trial of pre-irradiation KRN8602 (MX2) in malignant glioma patients. Journal of neuro-oncology, 2000, Volume: 48, Issue:2 Topics: Adult; Antibiotics, Antineoplastic; Astrocytoma; Brain Neoplasms; Cardiomyopathies; Carubicin; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Glioblastoma; Humans; Leukopenia; Male; Middle Aged; Nausea; Oligodendroglioma; Treatment Outcome; Vomiting	2000

Other Studies

1 other study(ies) available for morpholinoanthracycline mx2 and Astrocytoma, Grade IV

Article	Year
[Antitumor effect of KRN 8602 for malignant brain tumors using collagen gel matrix assay]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:10 Topics: Animals; Antibiotics, Antineoplastic; Brain Neoplasms; Carubicin; Collagen; Drug Screening Assays, Antitumor; Gels; Glioblastoma; Humans; Medulloblastoma; Mice; Neoplasm Transplantation; Tumor Cells, Cultured	1995